AU6378199A - A new composition - Google Patents

A new composition

Info

Publication number
AU6378199A
AU6378199A AU63781/99A AU6378199A AU6378199A AU 6378199 A AU6378199 A AU 6378199A AU 63781/99 A AU63781/99 A AU 63781/99A AU 6378199 A AU6378199 A AU 6378199A AU 6378199 A AU6378199 A AU 6378199A
Authority
AU
Australia
Prior art keywords
treatment
component
pharmaceutical formulation
disorders
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63781/99A
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU6378199A publication Critical patent/AU6378199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU63781/99A 1998-09-16 1999-09-13 A new composition Abandoned AU6378199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803157 1998-09-16
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition
PCT/SE1999/001598 WO2000015219A1 (en) 1998-09-16 1999-09-13 A new composition

Publications (1)

Publication Number Publication Date
AU6378199A true AU6378199A (en) 2000-04-03

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63781/99A Abandoned AU6378199A (en) 1998-09-16 1999-09-13 A new composition

Country Status (21)

Country Link
EP (1) EP1121119A1 (ko)
JP (1) JP2002524509A (ko)
KR (1) KR20010099648A (ko)
CN (1) CN1317963A (ko)
AR (1) AR023657A1 (ko)
AU (1) AU6378199A (ko)
BR (1) BR9913765A (ko)
CA (1) CA2342585A1 (ko)
CZ (1) CZ2001962A3 (ko)
EE (1) EE200100156A (ko)
HU (1) HUP0103569A3 (ko)
ID (1) ID28359A (ko)
IL (1) IL141520A0 (ko)
IS (1) IS5877A (ko)
NO (1) NO20011313L (ko)
PL (1) PL346769A1 (ko)
SE (1) SE9803157D0 (ko)
SK (1) SK3272001A3 (ko)
TR (1) TR200100769T2 (ko)
WO (1) WO2000015219A1 (ko)
ZA (1) ZA200101951B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
WO2006123243A2 (en) 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
KR20010099648A (ko) 2001-11-09
TR200100769T2 (tr) 2001-11-21
EE200100156A (et) 2002-08-15
HUP0103569A3 (en) 2002-03-28
SE9803157D0 (sv) 1998-09-16
PL346769A1 (en) 2002-02-25
IS5877A (is) 2001-03-05
CN1317963A (zh) 2001-10-17
JP2002524509A (ja) 2002-08-06
ZA200101951B (en) 2002-06-10
NO20011313L (no) 2001-05-16
NO20011313D0 (no) 2001-03-15
ID28359A (id) 2001-05-17
HUP0103569A2 (hu) 2002-02-28
BR9913765A (pt) 2001-06-05
CA2342585A1 (en) 2000-03-23
AR023657A1 (es) 2002-09-04
IL141520A0 (en) 2002-03-10
WO2000015219A1 (en) 2000-03-23
EP1121119A1 (en) 2001-08-08
CZ2001962A3 (cs) 2001-08-15
SK3272001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
US6184218B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
AU2007253684A1 (en) Treatment for depressive disorders
JP4571485B2 (ja) Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用
BRPI0713733A2 (pt) métodos para diminuir os sintomas de depressão e para tratar uma ou mais condições psicológicas, composição farmacêutica e kit
US6472423B1 (en) Pharmaceutical composition
JP2002511414A (ja) 神経疾患のための新しい治療
AU6378199A (en) A new composition
AU6378299A (en) A new composition
AU6377999A (en) A new composition
AU6378099A (en) A new composition
JP2002511408A (ja) 神経疾患のための新しい治療
JP4571645B2 (ja) Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用
MXPA01002543A (en) A new composition
MXPA01002370A (en) A new composition

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted